Tg Therapeutics (TGTX) Inventory (2023 - 2026)

Tg Therapeutics' Inventory history runs 4 years deep, the most recent figure standing at $129.0 million for Q1 2026.

• In Q1 2026, Inventory fell 18.21% year-over-year to $129.0 million; the TTM figure through Mar 2026 stood at $129.0 million (down 18.21% YoY), while the FY2025 annual figure was $125.6 million, up 13.7% from the prior year.
• Inventory for Q1 2026 stood at $129.0 million, up from $125.6 million in the prior quarter.
• The five-year high for Inventory was $157.8 million in Q1 2025, with the low at $27.2 million in Q1 2023.
• The 4-year median for Inventory is $84.7 million (2024), against an average of $92.3 million.
• The sharpest annual moves came in 2024 and 2026: Inventory jumped 185.51% in 2024, then fell 18.21% in 2026.
• Tg Therapeutics' Inventory stood at $39.8 million in 2023, then jumped by 177.37% to $110.5 million in 2024, then grew by 13.7% to $125.6 million in 2025, then rose by 2.74% to $129.0 million in 2026.
• Business Quant data shows TGTX's Inventory at $129.0 million in Q1 2026, $125.6 million in Q4 2025, and $147.0 million in Q3 2025.